# Effect of Buscopan on Gastrointestinal Imaging Quality With Probe-based Confocal Laser Endomicroscopy

> **NCT02725398** · NA · UNKNOWN · sponsor: **Xijing Hospital of Digestive Diseases** · enrollment: 150 (estimated)

## Conditions studied

- Gastrointestinal Imaging With pCLE

## Interventions

- **DRUG:** Buscopan
- **DRUG:** Scopolamine
- **DRUG:** physiological saline

## Key facts

- **NCT ID:** NCT02725398
- **Lead sponsor:** Xijing Hospital of Digestive Diseases
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2016-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02725398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02725398, "Effect of Buscopan on Gastrointestinal Imaging Quality With Probe-based Confocal Laser Endomicroscopy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02725398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
